JINARC

This brand name is authorized in Australia, Austria, Canada, Croatia, Estonia, Finland, France, Hong Kong SAR China, Ireland, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Spain, Turkey, UK.

Active ingredients

The drug JINARC contains one active pharmaceutical ingredient (API):

1	Tolvaptan UNII 21G72T1950 - TOLVAPTAN
	Tolvaptan is a selective vasopressin V2-receptor antagonist that specifically blocks the binding of arginine vasopressin (AVP) at the V2-receptor of the distal portions of the nephron. Tolvaptan affinity for the human V2-receptor is 1.8 times that of native AVP.
	Read more about Tolvaptan

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
JINARC Tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C03XA01	Tolvaptan	C Cardiovascular system → C03 Diuretics → C03X Other diuretics → C03XA Vasopressin antagonists
Discover more medicines within C03XA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	11588X, 11593E, 11596H, 11597J, 11600M, 11602P, 12457P, 12460T, 12461W, 12462X
CA	Health Products and Food Branch	02437503, 02437511, 02437538, 02491575, 02491583
EE	Ravimiamet	1686551, 1686562, 1686573, 1686584, 1686607, 1686641, 1686652, 1686663, 1686674, 1686685, 1686696, 1686708, 1686719
ES	Centro de información online de medicamentos de la AEMPS	1151000001, 1151000003, 1151000007, 1151000010, 1151000013
FI	Lääkealan turvallisuus- ja kehittämiskeskus	069019, 111615, 582720
FR	Base de données publique des médicaments	61666369, 63026453, 64598514, 66056341, 68174566
GB	Medicines & Healthcare Products Regulatory Agency	310164, 310167, 310577, 310580, 310582, 310585, 310596, 310603
HK	Department of Health Drug Office	65098, 65099, 65100, 65101, 65102
IE	Health Products Regulatory Authority	88940, 88941, 88942, 88943, 88944
IT	Agenzia del Farmaco	044202012, 044202024, 044202036, 044202048, 044202051, 044202063, 044202075, 044202087, 044202099, 044202101, 044202113, 044202125, 044202137, 044202149, 044202152, 044202164, 044202176, 044202188, 044202190, 044202202, 044202214, 044202226
LT	Valstybinė vaistų kontrolės tarnyba	1076760, 1076761, 1076762, 1076763, 1076764, 1076765, 1076766, 1076767, 1076768, 1076769, 1076770, 1076771, 1076772, 1086946, 1086947, 1086948, 1086949, 1086950, 1086951, 1086952, 1086953, 1086954
NL	Z-Index G-Standaard, PRK	128228, 128236, 128279, 128287, 128295
NZ	Medicines and Medical Devices Safety Authority	20038, 20058, 20059, 20060, 20061
PL	Rejestru Produktów Leczniczych	100347380, 100347410, 100347427, 100347440, 100347456
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W66510001, W66511001, W66512001
TR	İlaç ve Tıbbi Cihaz Kurumu	8680683010170, 8680683010187, 8680683010194, 8680683010200